Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma

Clinical Trial ID NCT00304031

Rank	Title	Journal	Year	PubWeight™‹?›
1	Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.	J Clin Oncol	2013	3.52
2	MGMT promoter methylation in malignant gliomas: ready for personalized medicine?	Nat Rev Neurol	2009	3.32
3	Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.	J Clin Oncol	2013	1.62
4	New (alternative) temozolomide regimens for the treatment of glioma.	Neuro Oncol	2008	1.58
5	Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.	Neuro Oncol	2009	0.87
6	Towards personalized therapy for patients with glioblastoma.	Expert Rev Anticancer Ther	2011	0.83
7	DecisionDx-GBM Gene Expression Assay for Prognostic Testing in Glioblastoma Multiform.	PLoS Curr	2010	0.78
8	Identifying radiotherapy target volumes in brain cancer by image analysis.	Healthc Technol Lett	2015	0.75
9	Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.	JAMA Oncol	2017	0.75